FDA
-
-
-
-
-
-
-
Artivion completes $175M acquisition of Endospan
-
-
-
-
-
-
-
Needham stays Buy on Artivion Inc. (AORT) amid NEXUS FDA approval
-
-
-
-
-
-
-
Artivion presents clinical trial data at thoracic surgery meeting
-
-
-
-
-
-
-
Artivion Inc. (AORT) PT Lowered to $40 at Oppenheimer
-
-
-
-
-
-
-
Artivion Announces Presentation of New Clinical Data from NEXUS TRIOMPHE IDE Trial at the 105th American Association for Thoracic Surgery (AATS) Annual Meeting
-
-
-
-
-
-
-
Artivion Reports Third Quarter 2024 Financial Results
-
-
-
-
-
-
-
Artivion Announces Presentation of New Clinical Data for On-X Aortic Heart Valve and AMDS at the 104th American Association for Thoracic Surgery (AATS) Annual Meeting
-
328,249 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

